Kathryn Gold
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03498378) | Kathryn Gold | 2018-06-06 |
Track Kathryn Gold automatically
Every clearance here is in the API, with alerts when new ones post.